Skip to main content
×
Home
    • Aa
    • Aa

No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial

  • Peter J. Rogers (a1), Katherine M. Appleton (a1), David Kessler (a2), Tim J. Peters (a2), David Gunnell (a3), Robert C. Hayward (a1), Susan V. Heatherley (a1), Leonie M. Christian (a1), Sarah A. McNaughton (a4) and Andy R. Ness (a5)...
Abstract

Low dietary intakes of the n-3 long-chain PUFA (LCPUFA) EPA and DHA are thought to be associated with increased risk for a variety of adverse outcomes, including some psychiatric disorders. Evidence from observational and intervention studies for a role of n-3 LCPUFA in depression is mixed, with some support for a benefit of EPA and/or DHA in major depressive illness. The present study was a double-blind randomised controlled trial that evaluated the effects of EPA+DHA supplementation (1·5 g/d) on mood and cognitive function in mild to moderately depressed individuals. Of 218 participants who entered the trial, 190 completed the planned 12 weeks intervention. Compliance, confirmed by plasma fatty acid concentrations, was good, but there was no evidence of a difference between supplemented and placebo groups in the primary outcome – namely, the depression subscale of the Depression Anxiety and Stress Scales at 12 weeks. Mean depression score was 8·4 for the EPA+DHA group and 9·6 for the placebo group, with an adjusted difference of − 1·0 (95 % CI − 2·8, 0·8; P = 0·27). Other measures of mood, mental health and cognitive function, including Beck Depression Inventory score and attentional bias toward threat words, were similarly little affected by the intervention. In conclusion, substantially increasing EPA+DHA intake for 3 months was found not to have beneficial or harmful effects on mood in mild to moderate depression. Adding the present result to a meta-analysis of previous relevant randomised controlled trial results confirmed an overall negligible benefit of n-3 LCPUFA supplementation for depressed mood.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Professor Peter J. Rogers, fax +44 0117 9288588, email Peter.Rogers@bristol.ac.uk
References
Hide All
1Simopoulos AP (1999) Essential fatty acids in health and chronic disease. Am J Clin Nutr 70, Suppl, 560S569S.
2SACN/COT (2004) Advice on Fish Consumption: Benefits and Risks. London: TSO.
3Hibbeln JR & Salem N (1995) Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 62, 19.
4Peet M, Glen I & Horrobin DF (1999) Phospholipid Spectrum Disorder in Psychiatry. Carnforth Lancashire: Marius Press.
5Rogers PJ (2001) A healthy body, a healthy mind: long-term impact of diet on mood and cognitive function. Proc Nutr Soc 60, 135143.
6Hallahan B & Garland MR (2004) Essential fatty acids and their role in the treatment of impulsivity disorders. Prost Leuk Ess Fatty Acids 71, 211216.
7Murray CJL & Lopez AD (1996) The Global Burden of Disease. Cambridge MA: Harvard School of Public Health.
8Chalon S, Delion-Vancassel S, Blezung C, Guilloteau D, Leguisquet AM, Besnard JC & Durand G (1998) Dietary fish oil affects monoaminergic neurotransmission and behaviour in rats. J Nutr 128, 25122519.
9Zimmer L, Delion-Vancassel S, Durand G, Guilloteau D, Bodard S, Besnard JC & Chalon S (2000) Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 41, 3240.
10Adams PB, Lawson S, Sanigorski A & Sinclair AJ (1996) Arachidonic to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depressed mood. Lipids 31, S167S176.
11Peet M, Murphy B, Shay J & Horrobin D (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43, 315319.
12Maes M, Christophe A, Delanghe J, Altamura C, Neels H & Meltzer HY (1999) Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiat Res 85, 275291.
13Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ & Breteler MM (2003) Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr 78, 4046.
14Mamalakis G, Tornaritis M & Kafatos A (2002) Depression and adipose essential polyunsaturated fatty acids. Prost Leuk Ess Fatty Acids 67, 311318.
15Noaghiul S & Hibbeln JR (2003) Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry 160, 22222227.
16Silvers KM & Scott KM (2002) Fish consumption and self-reported physical and mental health status. Public Health Nutr 5, 427431.
17Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Viinamaki H, Lehtonen J & Vartiainen E (2001) Fish consumption and depressive symptoms in the general population in Finland. Psychiatric Services 52, 529531.
18Appleton KM, Peters TJ, Hayward RC, Heatherley SV, McNaughton SA, Gunnell D, Rogers PJ, Ness AR & Kessler D (2007) Depressed mood and n3 polyunsaturated fatty acid intake from fish: Non-linear or confounded association? Soc Psychiatry Psychiatr Epidemiol 42, 100104.
19Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D & Lonnqvist J (2004) Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry 161, 567569.
20Ellis FR & Sanders TA (1977) Long-chain polyunsaturated fatty acids in endogenous depression. J Neurol Neurosur Psychiatry 40, 168169.
21Appleton KM, Hayward RC, Gunnell D, Peters TJ, Rogers PJ, Kessler D & Ness AR (2006) Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr 84, 13081316.
22Lovibond PF & Lovibond SH (1995) The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck depression and anxiety inventories. Behav Res Therapy 33, 335343.
23Winkler D, Pjrek E & Kasper S (2005) Anger attacks in depression: evidence for a male depressive syndrome. Psychother Psychosom 74, 303307.
24Austin MP, Mitchell P & Goodwin GM (2001) Cognitive deficits in depression: possible implications for functional neuropathy. Brit J Psychiatry 178, 200206.
25Kalmijn S, van Boxtel MJP, Ocké M, Verschuren WMM, Kromhout D & Launer LJ (2004) Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 62, 275280.
26Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S & Lodi L (2005) Cognitive and physiological effects of omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 35, 691699.
27Jenkins R, Lewis G, Bebbington P, Brugha T, Farrell M, Gill B & Meltzer H (1997) The National Psychiatric Morbidity Surveys of Great Britain: initial findings from the Household Survey. Psychol Med 27, 755789.
28Lovibond SH & Lovibond PF (1995) Manual for the Depression Anxiety and Stress Scales. Sydney: Psychology Foundation of Australia Inc.
29Beck AT & Steer RA (1987) Beck Depression Inventory Manual. San Antonio, Texas: Psychological Corporation.
30Goldberg D & Williams P (1988) A User's Guide to the General Health Questionnaire. Basingstoke, Hampshire: NFER-Nelson Publishing.
31Spielberger CD (1991) State-Trait Anger Expression Inventory: Professional Manual. Odessa, Florida: Psychological Assessment Resources Inc.
32Polet P, Rogers PJ, Wardle J, Atkinson EA, Vallis L, Rapoport L, Taylor M & Judd P (1998) Mood effects of reduced-fat dietary treatment. Proc Nutr Soc 57, 83A.
33MacLeod C & Mathews A (1988) Anxiety and the allocation of attention to threat. Q J Exp Psychol 40, 653670.
34Mogg K & Bradley BP (2005) Attentional bias in generalized anxiety disorder versus depressive disorder. Cognitve Ther Res 29, 2945.
35Rogers PJ, Heatherley SV, Hayward RC, Seers HE, Hill J & Kane M (2005) Effects of caffeine and caffeine withdrawal on mood and cognitive performance degraded by sleep deprivation. Psychopharmacology 179, 742752.
36Brown RG, Scott LC, Bench CJ & Dolan RJ (1994) Cognitive function in depression: its relationship to the presence and severity of intellectual decline. Psychol Med 24, 829847.
37Weschler D (1997) Weschler Adult Intelligence Scale, 3rd ed., San Antonio, TX: Psychological Corporation.
38Baddeley A (1986) Working Memory. Oxford: Clarendon Press.
39Rabbitt P, Donlan C, Watson P, McInnes L & Bent L (1995) Unique and interactive effects of depression, age, socio-economic advantage and gender on cognitive performance of normal healthy older people. Psychol Aging 10, 307313.
40Sackeim HA, Keilp JG, Rush AJ, et al. (2001) The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatr Neuropsychol Behav Neurol 14, 5362.
41Burdge GC, Wright P, Jones AE & Wootton SA (2000) A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Brit J Nutr 84, 781787.
42Silvers KM, Woolley CC, Hamilton FC, Watts PM & Watson RA (2005) Randomized double-blind placebo-controlled trial of fish oil in the treatment of depression. Prost Leuk Ess Fatty Acids 72, 211218.
43Nemets B, Stahl Z & Belmaker RH (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159, 477479.
44Peet MB & Horrobin DF (2002) A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59, 913919.
45Su K-P, Huang S-Y, Chiu C-C & Shen WW (2003) Omega-3 fatty acids in major depressive disorder – a preliminary double-blind placebo-controlled trial. Eur Neuropsychopharm 13, 267271.
46Hirashima F, Parow AM, Stoll AL, Demopulos CM, Damico KE, Rohan ML, Eskesen JG, Zuo CS, Cohen BM & Renshaw PF (2004) Omega-3 fatty acid treatment and T2 whole brain relaxation times in bipolar disorder. Am J Psychiatry 161, 19221924.
47Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK & Marangell LB (1999) Omega-3 fatty acids in bipolar disorder – a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56, 407412.
48Fenton WS, Dickerson F, Boronow J, Hibbeln JR & Knable M (2001) A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry 158, 20712074.
49Llorente AM, Jensen CL, Voigt RG, Fraley JK, Berretta MC & Heird WC (2003) Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol 188, 13481353.
50Marangell LB, Martinez JM, Zboyan HA, Kertz B, Seung Kim HF & Puryear LJ (2003) A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 160, 996998.
51Ness AR, Gallacher JEJ, Bennett PD, Gunnell DJ, Rogers PJ, Kessler D & Burr ML (2003) Advice to eat fish and mood: a randomised controlled trial in men with angina. Nutr Neurosci 6, 6365.
52Zanarini MC & Frankenburg MD (2003) Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiat 160, 167169.
53Frangou S, Lewis M & McCrone P (2006) Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Brit J Psychiatry 188, 4650.
54Nemets H, Nemets B, Apter A, Bracha Z & Belmaker RH (2006) Omega-3 treatment of children's depression: a controlled, double-blind pilot study. Am J Psychiatry 163, 10981100.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 37
Total number of PDF views: 392 *
Loading metrics...

Abstract views

Total abstract views: 599 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 20th October 2017. This data will be updated every 24 hours.